Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Quetiapine in Specific Phobia (QUISS)

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
University Hospital Muenster
ClinicalTrials.gov Identifier:
NCT00872716
First received: March 30, 2009
Last updated: March 30, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)